Movicol Flüssig Orangengeschmack

Macrogol 3350, the active ingredient in Movicol Flüssig Orangengeschmack, is an osmotic laxative presented as an oral liquid solution for oral use. It is used to relieve constipation and to prepare the bowel for diagnostic procedures in adults and children as prescribed.

GNH USA supplies Movicol Flüssig Orangengeschmack as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Movicol Flüssig Orangengeschmack is an osmotic laxative used in the management of constipation‑related conditions.

- Constipation: softens stool and facilitates regular bowel movements. - Fecal impaction: helps to break down hardened stool for easier evacuation. - Bowel preparation for diagnostic procedures: clears the intestinal tract to improve visibility during colonoscopy or imaging studies.

Movicol Flüssig Orangengeschmack may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Abdominal bloating - Flatulence - Nausea - Abdominal cramps - Increased thirst - More frequent stools

Serious or Rare Side Effects: - Severe dehydration - Electrolyte imbalance (e.g., low potassium or sodium) - Allergic reactions such as rash or swelling - Severe abdominal pain - Rectal bleeding - Persistent vomiting

Before prescribing Movicol Flüssig Orangengeschmack, consider the following safety measures.

- Renal function assessment: evaluate kidney status, especially in patients with chronic kidney disease. - Electrolyte monitoring: check serum electrolytes in patients at risk of imbalance. - Caution in dehydration: avoid use in severely dehydrated individuals without rehydration. - Hypersensitivity: discontinue if an allergic reaction occurs. - Pediatric dosing: adjust dose according to age and weight under medical supervision. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Movicol Flüssig Orangengeschmack can interact with other medicines that affect fluid or electrolyte balance.

Major Interactions (Avoid): - Concurrent use of other osmotic laxatives: may cause excessive fluid loss. - Loop diuretics: increased risk of electrolyte disturbances. - Mineralocorticoid antagonists (e.g., spironolactone): potential for severe hyponatremia.

Moderate Interactions (Monitor Closely): - NSAIDs: may impair renal function when combined with the laxative. - ACE inhibitors or ARBs: monitor blood pressure and electrolytes. - Anticholinergic agents: may reduce the laxative effect.